16
Participants
Start Date
July 7, 2020
Primary Completion Date
December 1, 2020
Study Completion Date
May 20, 2021
Benaglutide Injection
All subjects received multiple doses (tid) of 0.06 mg, 0.1 mg, 0.14 mg, and 0.2 mg in sequence, followed by the next dose after completing the previous multiple dosing. The administration time of each dose was 0.06 mg for 3 days, 0.1 mg for 3 days, 0.14 mg for 5 days, and 0.2 mg for 5 days.
The Affiliated Hospital of Qingdao University, Qingdao
The Affiliated Hospital of Qingdao University
OTHER